Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON41980
NL-OMON41980
Completed
Not Applicable

A Phase 1, Single-Center, Single-Blind, Placebo and Propofol Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous (IV) Infusion Doses of ABP-700 - ANVN-02 (CS0224)

Annovation Biopharma, Inc. (a wholly owned subsidiary of The Medicines Company, Inc.)0 sites72 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsanesthesiaNot applicable

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
anesthesia
Sponsor
Annovation Biopharma, Inc. (a wholly owned subsidiary of The Medicines Company, Inc.)
Enrollment
72
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Annovation Biopharma, Inc. (a wholly owned subsidiary of The Medicines Company, Inc.)

Eligibility Criteria

Inclusion Criteria

  • •Healthy adult men and/or women between 18 and 45 years of age (inclusive)

Exclusion Criteria

  • •Clinical significant abnormalities at medical research

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A Phase 1, Single-Center, Double-Blind, Placebo Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ABP-700 after a Single Ascending Bolus DoseanesthesiaNot applicable
NL-OMON40883Annovation Biopharma, Inc.60
Unknown
Phase 1
A Phase 1, Single-Blind, Randomized, Placebo-Controlled, Single-Dose or Open-Label Multiple-Dose Study of KHK4083 in Healthy Adults and Subjects with Ulcerative ColitisHealthy men and subjects with ulcerative colitis
JPRN-jRCT2080223390Kyowa Hakko Kirin Co., Ltd.52
Completed
Phase 1
A Phase 1, Single-Center, Randomized, Placebo-Controlled, Ascending Single-Dose Study of the Pharmacokinetics, Safety, and Tolerability of Oral XG005 in Healthy VolunteersChronic Pain
ACTRN12617001330336Xgene Pharmaceutical Inc.50
Completed
Phase 1
A Phase 1 Single-Center, Randomized, Placebo-Controlled, Double-Blind Pilot Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Candidate Topical Antimicrobial (NEO101) in the Reduction of Propionibacterium acnes among Healthy Young Adult MePropionibacterium acnes amongst healthy volunteersSkin - Dermatological conditions
ACTRN12606000424505eosil, Inc.30
Unknown
Not Applicable
A Phase 1, Single-Center, Single-Blind, Placebo and Propofol Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous (IV) Infusion Doses of ABP-700Preliminary safety study
NL-OMON25748Annovation Biopharma, University Medical Center Groningen (UMCG)48